Wed, 3 June 2020
Moderna has gone from your standard biotech to one of the hot stocks of 2020 over the past few months as the company has worked on a COVID-19 vaccine. Shares are up around 200% since the pandemic hit, and the company has made some moves that seem odd on first pass.
We use the company's dramatic rise and position as a clinical-stage business to explore insider selling, raising capital, and the business of biotechs.
Check out more of our content here: